Your Health and Fitness Partner: Androxal & FitHub

We are also excited to expand our scope by including valuable information on Androxal, a potent medication beneficial in various medical conditions. This remarkable drug, derived from the testosterone molecule, has made its mark significantly in the field of endocrinology. Patients and medical professionals can rely on our comprehensive, unbiased, and scientifically grounded content on Androxal for gaining a robust understanding of its uses, side effects, and the latest studies related to it. We understand the necessity of accurate information when it comes to medication. Our newly launched section dedicated to Androxal aims at not only educating the readers about its nuances but also at contributing beneficially to their wellbeing. Stay tuned for insightful articles unraveling the potential of Androxal in medical science.

Sitemap | Policies | Feedback    
 About the Journal
Editorial Board
Journal Subscription
Instructions for Authors
E-mail Alerts
Forthcoming Events
Advertise with Us
Contact Us
 
Article Options
FULL TEXT
PDF
Printer Friendly Version
Search Pubmed for
Search Google Scholar for
Article Statistics
Bookmark and Share
Case Report
 
Biliary papillomatosis withadenocarcinoma arising incholedochal cyst
Keywords :
Sanjay Singh Negi, Ranjana Gondala, Darsh Chaudhary
Room No. 2208A,
Sir Ganga Ram Hospital,
Rajinder Nagar,
New Delhi-110060 (India)


Corresponding Author
: Dr. Adarsh Chaudhary
Email : chauadarsh@gmail.com


DOI: http://dx.doi.org/

48uep6bbphidvals|173
48uep6bbphidcol4|ID
48uep6bbph|2000F98CTab_Articles|Fulltext

Choledochal cyst is a premalignant condition of biliary tract.The development of malignancy in association withcholedochal cyst has been reported in 2.5-26% cases.[1] Sucha malignant change may occur anywhere in the biliary tract orin the pancreas. However, biliary papillomatosis rarelydevelops in a choledochal cyst and only two such cases havebeen reported so far.[2] We herein detail a case of biliarypapillomatosis with papillary adenocarcinoma in a patient withcholedochal cyst.

Case Report

A 50-year-male presented with fluctuating jaundice andcholestatic symptoms of 4 months duration. On examinationhe was jaundiced and had a 4 cm x 4 cm right-sided parietallump in the periumbilical region. The liver function tests wereconsistent with cholestatic jaundice. Abdominal ultrasoundrevealed dilated bile duct with intraluminal hyperechoic mass.Magnetic resonance cholangiography demonstrated Todanitype IVa choledochal cyst with an irregular intraluminal fillingdefect in the common bile duct, there was no evidence ofabnormal pacreato-biliary duct junction (Figure 1). Contrastenhanced computed tomography of the abdomendemonstrated dilated intrahepatic biliary radicles with localisedenhancing intraluminal mass in the supraduodenal commonbile duct and enhancing mass in relation to the right rectusmuscle. Fine needle aspiration cytology from the parietal walllump was inconclusive. In view of the localised nature of themass in the common bile duct, doubtful nature of parietal wallnodule and good performance status of patient, surgicalexploration was planned. Laparotomy revealed a dilated bileduct with a localised intraluminal soft tissue mass in thesupraduodenal part of the bile duct. There was no evidence ofregional lymphadenopathy. The parietal wall mass waslocalised to the right rectus muscle sparing the rectus sheathand peritoneum. The patient underwent complete excision ofthe extra-hepatic bile duct with Roux-en-Y-hepaticojejunostomy, excision of the right rectus muscle andnodule, and biopsy from both lobes of liver. The bile duct wasfilled with gelatinous mucoid material. The cut section of thebile duct revealed three soft, fleshy, cauliflower-shapedpedunculated masses with wide stalks. The frozen sectionsfrom the proximal and distal margins were free of tumour. Oneof the masses measured 6 cm x 6 cm and the remaining twowere 2 cm x2 cm in size. The parietal mass was greyish, hardand gritty with a variegated appearance and measured 4 cm x5 cm. Microscopic examination of the bile duct growthsrevealed papillomas with connective tissue stroma and frond-like branches lined with columnar epithelium. The largestgrowth had several foci of moderate to severe nuclear atypiaand an area of moderately differentiated papillaryadenocarcinoma with invasion of cyst wall and periductularneural plexus (Figure 2). Sections from the remaining cyst revealed absence of mucosa in most parts and evidence ofmixed inflammatory infiltrate. The resection margins of thecyst and pericholedochal lymph nodes were free of tumour.Sections from the parietal wall nodule revealed papillaryadenocarcinoma and liver biopsy showed evidence ofextensive hepatic fibrosis. Postoperatively the patientdeveloped ascites and wound infection, which responded wellto conservative measures. The patient was discharged twoweeks later and was doing well up until four and a half yearsafter surgery when he developed diffuse bilateral hepaticmetastasis and died.





Discussion

Biliary papillomatosis is an uncommon clinicopathologicalentity characterised by multiple papillary adenomas of thebiliary epithelium. Such lesions may involve any part of thebiliary tract including the gall bladder. These lesions producelarge amount of jelly-like mucus, which may lead to intermittentbiliary obstruction and cholangitis.3 Although histologically categorised as benign, biliary papillomatosis should beconsidered a premalignant lesion as malignant transformationhas been observed in 35% of cases at the time of presentationor on follow-up.[4] Biliary papillomatosis may demonstrate notonly dysplastic changes but also progression to carcinoma-in-situ and frankly invasive adenocarcinoma.[5] Hence, it hasbeen suggested that the adenoma-carcinoma sequence  maybe seen in these lesions.[4] The median age at diagnosis inreported series of patients with biliary papillomatosis is 58years with slight male preponderance and the majority ofpatients present with intermittent obstructive jaundice.[4] maging studies may reveal dilatation of the biliary tree withmultiple ill-defined and fuzzy filling defects or intraluminal frond-like mass lesions.[6] Curettage and drainage procedures areassociated with recurrence in almost all the patients.[4] Radicalsurgery in the form of bile duct excision,pancreaticoduodenectomy and hepatectomy is the treatmentof choice7 and is associated with 14% local recurrence rate.[4] After complete surgical excision with pathologically clearmargins, local recurrence can still occur in the remnant biliarytract.[7] Distant metastasis has rarely been reported with biliarypapillomatosis.[7,8] n fact, 5-year survival was observed in apatient with biliary papillomatosis with abdominal wall andpulmonary metastasis after surgical excision.[7]

Biliary papillomatosis has been rarely reported inassociation with choledochal cysts and only 2 such caseshave been reported so far.[2,9] Mutation of K-ras and the p53gene has been suggested as the underlying mechanism inthe pathogenesis of these lesions.[2,9] Although not present inthis case, anomalous pancreato-biliary duct junction may alsoplay a role in themalignant change in these lesions.[2] To thebest of our knowledge, biliary papillomatosis with papillaryadenocarcinoma arising in choledochal cyst has not beenreported so far. The treatment of choice for choledochal cyst iscomplete excision of the extrahepatic bile duct withhepaticojejunostomy.

References

  1. Fieber SS, Nance FC. Choledochal cyst and neoplasm: acomprehensive review of 106 cases and presentation of twooriginal cases. Am Surg. 1997;63:982–7.
  2. Iwasaki Y, Shimoda M, Furihata T, Rokkaku K, Sakuma A, IchikawaK, et al. Biliary papillomatosis arising in a congenital choledochalcyst: report of a case. Surg Today. 2002;32:1019–22.
  3. Styne P, Warren GH, Kumpe DA, Halgrimson C, Kern F. Obstructivecholangitis secondary to mucus secreted by a solitary papillarybile duct tumor. Gastroenterology. 1986;90:748–53.
  4. Holtkamp W, Reis HE. Papillomatosis of the bile ducts: papilloma-carcinoma sequence. Am J Gastroenterol. 1994;89:2253–5.
  5. Neumann RD, LiVolsi VA, Rosenthal NS, Burrell M, Ball TJ.Adenocarcinoma in biliary papillomatosis. Gastroenterology.1976;70:779–82.
  6. Ma KF, Iu PP, Chau LF, Chong AK, Lam HS. Clinical and radiologicalfeatures of biliary papillomatosis. Australas Radiol. 2000;44:169–73.
  7. Lam CM, Yuen ST, Yuen WK, Fan ST. Biliary papillomatosis. Br JSurg. 1996;83:1715–6.
  8. Rambaud S, Nores JM, Meeus F, Paolaggi JA. Malignantpapillomatosis of the bile ducts: a new indication for livertransplantation? Am J Gastroenterol. 1989;84:448–9.
  9. Ohita H, Yamaguchi Y, Yamakawa O, Watanabe H, Satomura Y,Motoo Y, et al. Biliary papillomatosis with the point mutation of K-ras gene arising in congenital choledochal cyst. Gastroenterology.1993;105:1209–12.